Novo Nordisk (NVO) Q3 2023 Earnings Call Transcript : vimars

NVO earnings call for the period ending September 30, 2023.

Related Keywords

United States , Philadelphia , Pennsylvania , China , Denmark , Chinese , Danish , America , American , Michael Nedelcovych , Societe Generale , Inversago Pharma , Peter Welford Jefferies , Doug Langa , Mattias Haggblom , Peter Welford , Mark Purcell , Richard Vosser Jpmorgan , Simon Baker Redburn , Richard Parkes Exane , Richard Vosser , Naresh Chouhan , Florent Cespedes Societe Generale , Mattias Haggblom Handelsbanken , Daniel Bohsen , Seamus Fernandez Guggenheim , Pete Verdult Citi , Florence Cespedes , Michael Novod , Karsten Munk Knudsen , Richard Parkes , Seamus Fernandez , Novo Nordisk , Martin Holst Lange , Mark Purcell Morgan Stanley , Simon Baker , Emmanuel Papadakis , Lars Fruergaard Jorgensen , Michael Novod Nordea , Camilla Sylvest , Peter Verdult , European Medicines Agency , American Heart Association Congress , Nordea , Naresh Chouhan Intron Health Analyst , Head Of Development , Citigroup , Corporate Affairs , Morgan Stanley , Company Analyst , Handelsbanken , Intron Health , Astrazeneca , Emmanuel Papadakis Deutsche Bank Analyst , Data Monitoring Committee , Barclays , American Heart Association , North America , Karsten Munk , Motley Fool Stock Advisor , Stock Advisor , Chief Executive , Vice President , Commercial Strategy , European Medicines , Chief Financial , Forma Therapeutics , American Heart , Emily Field , Capital Markets , Guggenheim Partners , Redburn Partners ,